Answer to the Letter to the Editor of A. Bilge, et al. concerning "Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients" by Narayanan R, Dalton J, A McCurdy M, et al. (Eur Spine J [2025] doi:10.1007/s00586-025-08764-6).
Publication/Presentation Date
12-1-2025
Volume
34
Issue
12
First Page
5832
Last Page
5834
ISSN
1432-0932
Published In/Presented At
Narayanan, R., Dalton, J., Baek, G., McCurdy, M. A., Issa, T. Z., Oris, R. J., Tomlak, A., Lee, Y., McCall, K., Norceide, D., Mangan, J. J., Kurd, M. F., Kaye, I. D., Canseco, J. A., Hilibrand, A. S., Vaccaro, A. R., Kepler, C. K., & Schroeder, G. D. (2025). Answer to the Letter to the Editor of A. Bilge, et al. concerning "Serotonin-norepinephrine reuptake inhibitor and gabapentinoid use independently predict greater postoperative opioid consumption in lumbar fusion patients" by Narayanan R, Dalton J, A McCurdy M, et al. (Eur Spine J [2025] doi:10.1007/s00586-025-08764-6). European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society, 34(12), 5832–5834. https://doi.org/10.1007/s00586-025-09378-8
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
41065786
Department(s)
Administration and Leadership
Document Type
Article